Spasmolysin

Spasmolysin contains Trospium chloride, an anticholinergic and antispasmodic agent. It works by blocking muscarinic receptors on the bladder smooth muscle, thereby reducing spasms, increasing bladder capacity, and delaying the initial urge to void.

Dosage by Body Weight

The standard adult dose is 20 mg twice daily, taken on an empty stomach at least one hour before meals. Dosage must be reduced to 20 mg once daily in patients with severe renal impairment. Safety and efficacy in children have not been established.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and efficacy in infants and pediatric patients have not been established.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and efficacy in pediatric patients have not been established.
  3. Body Weight
    8-10 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and efficacy in pediatric patients have not been established.
  4. Body Weight
    11-15 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and efficacy in pediatric patients have not been established.
  5. Body Weight
    16-20 kg
    Dose
    Not recommended
    Frequency
    N/A
    Tracking Notes
    Safety and efficacy in pediatric patients have not been established.

Formulation

TabletCoated Tablet

Purpose

Treatment of overactive bladder (OAB) symptoms, including urinary urgency, frequency, and urge incontinence.

Generic Name

Trospium chloride

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

SpasmexSancturaOxybutyninTolterodineSolifenacin

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.